Navigation Links
Leukemia Drug Breakthrough Study In New England Journal Of Medicine

Alan List, M.D., leader of the Hematologic Malignancies Program at the H. Lee Moffitt Cancer Center & Research Institute, recently conducted a phase I/II trial of the experimental drug Revlimid showing promise as an innovative way to treat patients with myelodysplastic syndrome (MDS), a form of pre-leukemia. Given in pill form, Revlimid simultaneously blocks the growth of new blood vessels that nourish tumors (anti-angiogenesis) and stimulates the immune system to fight cancer cells. The study is reported in the Feb.10 issue of the New England Journal of Medicine.

Nearly 90 percent of MDS patients are anemic and require regular transfusions of red cells. In this study, 91 percent of the MDS patients with a chromosome abnormality named 5q minus syndrome became transfusion independent. The defective 5q chromosome abnormality may be linked to other serious cancers, including leukemias and small cell lung cancer.

In another finding of the same study, all the patients with the 5q deletion who became transfusion independent also went into cytogenetic remission, meaning that the chromosome abnormality disappeared.

List, a professor of interdisciplinary oncology at the University of South Florida, initially developed the phase I clinical trial of Revlimid for treatment of MDS following his laboratory observations that the agent improved the growth of red blood cell precursors from MDS bone marrow. Celgene will submit the seminal findings of List's phase I trial - along with data from two recent confirmatory phase II clinical trials performed nationwide involving more than 350 patients with red blood cell transfusion-dependent MDS - to the U.S. Food and Drug Administration in a new drug application (NDA) for Revlimid as an innovative approach to treat the anemia of MDS patients with the 5q minus deletion.

In 2001, the National Cancer Institute awarded Moffitt the status of a Comprehensive Cancer Center in recognition of its excellence in re
'"/>

Source:University Of South Florida Health Sciences Center


Page: 1 2

Related biology news :

1. Protein That Promotes Survival Of Stem Cells Might Be Key To Poor Leukemia Prognosis
2. Genetically Modified Natural Killer Immune Cells Attack, Kill Leukemia Cells
3. Loosen up, DNA: Leukemia gene changes genetic packaging
4. Leukemia drug turns mini-molecules up, cancer genes down
5. Breakthrough Microarray-based Technology for the Study of Cancer
6. Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications
7. Breakthrough isolating embryo-quality stem cells from blood
8. Breakthrough System for Understanding Ocean Plant Life Announced
9. Breakthrough: Scientists create worlds tiniest organic particles
10. Breakthrough in micro-device fabrication combines biology and synthetic chemistry
11. Sciences Breakthrough of the Year: Watching evolution in action
Post Your Comments:
(Date:5/15/2008)...ational Laboratory has signed a memorandum of unde...atory (SRNL) to collaborate on nuclear energy and ...ort of critical U.S. Energy Department (DOE) needs... MOU allows Argonne to remain a leader in nuclear ...aid. "Argonne has the nation,s largest concentrati...
(Date:5/15/2008)... tuna aggregate under floating objects, such as le...arine mammals. There is still no full explanation ...ars have seen purse-seine fishery operators take a... Fishermen cast off floating rafts equipped with b...t, deployed in a wide arc on either side of the ve...
(Date:5/14/2008)...Linux, Security, and Low Power ...Newswire/ -- Silex Technology today announced,the ...igned for connecting,devices that require low powe...etworks (WLANs). It is ideal for mobile OEM applic...wer usage, such as battery-operated,portable devic...
(Date:5/14/2008)...ce widespread in the Pacific Northwests western lo...ression, conifer and invasive plant encroachment, ...s much as 99 percent of the oak communities histor...new technical report titled "Evaluation of Landsca...rie, Washington" outlines the findings of a study ...
Breaking Biology News(10 mins):Argonne-SRNL agreement supports critical DOE, national priorities 2Does fishing on drifting fish aggregation devices endanger the survival of tropical tuna? 2Does fishing on drifting fish aggregation devices endanger the survival of tropical tuna? 3New Silex SX-560 Enables Enterprise 802.11 Wireless Connectivity for Battery Operated Devices 2On a roll 3A MIT researchers devise new cell sorting system 13782 1On a roll 3A MIT researchers devise new cell sorting system 13782 2Curing addiction with cannabis medicines 13779 1Curing addiction with cannabis medicines 13779 2Teenage girls arent the only ones who tan indoors older adults do so as well 13777 1Teenage girls arent the only ones who tan indoors older adults do so as well 13777 2Multiple resource management is focus of new technical report 2436 1
...s a major cause of death among children in develop...ddressed by national or international health organ... at St. Jude Children’s Research Hospital. This gr... number of children dying from infectious diseases... Health Organization and international charities, ...
...tifies a critical inhibitory step that is a key co...ance between neutrophil production and destruction...munity, suggests that the process for disposal of ... production. A clear understanding of the processe...to the development of future therapeutics for cond...
...s at the gas pump could come in the form of cornco...mass, according to a joint feasibility study for t...cently completed Oak Ridge National Laboratory rep...n dry tons of biomass ?any organic matter that is ... displace 30 percent of the nation,s petroleum con...
...the freely available online journal PLoS Medicine,..., Kenya, show that the protection against malaria ...obin may involve the immune system. Studying a gro...f coastal Kenya, they found that this protection i...eclined. , It is estimated that cases of malaria c...
Other Biology News:Emergence of cancer as major cause of childhood death in developing countries is not being adequately addressed 2Emergence of cancer as major cause of childhood death in developing countries is not being adequately addressed 3White Blood Cell 'Waste Disposal' System Plays Critical Regulatory Role 2Growth in biomass could put US on road to energy independence 2
(Date:5/15/2008)...nt in Principle Reached to Terminate Marketing Agr...ne-6(TM) on Most Favorable Terms, NAPA, Calif., M...ulletin Board: SNKTY), a Life Sciences company eng...t the science of healthy aging, today announced,fi...08 and an agreement in,principle to terminate its ...
(Date:5/15/2008)...NVILLE, S.C., May 15 /- Sig...as appointed Mr. Lee B. Ehrlichman to,the company,...ompany,s,Director of Operations. Mr. Ehrlichman, w... technology and call center monitoring as CEO and,...rsee all company,operations as the company,s Opera...
(Date:5/15/2008)...YORK, May 15 /- Cadus Corpo...financial results for the first,quarter ended Marc...08 were $100,000, compared to,$100,000 for the sam...f,2008 was $207,996, compared to net loss of $558,...et loss can be attributed to a decrease in general...
(Date:5/15/2008)...YORK and BARCELONA, Spain, May 15 /PRNewswire-Firs... and Laboratorios Almirall, S.A. (ALM.MC),will hos... and pre-clinical,data findings presented at the A...ast, which will include a slide presentation and a...8 at 9:30am New York time, 3:30pm CET,2:30pm UKT....
Breaking Biology Technology:Senetek PLC Reports First Quarter 2008 Financial Results 2Senetek PLC Reports First Quarter 2008 Financial Results 3Signalife Appoints Lee Ehrlichman as Company Director and Operations Director; Additional Notice Received From Amex Regarding Sharholders' Equity Deficiency 2Signalife Appoints Lee Ehrlichman as Company Director and Operations Director; Additional Notice Received From Amex Regarding Sharholders' Equity Deficiency 3Signalife Appoints Lee Ehrlichman as Company Director and Operations Director; Additional Notice Received From Amex Regarding Sharholders' Equity Deficiency 4Cadus Reports First Quarter 2008 Results 2Cadus Reports First Quarter 2008 Results 3Forest Laboratories, Inc. and Laboratorios Almirall, S.A. to Host Webcast to Discuss Aclidinium Bromide Data Presentations at the American Thoracic Society Annual Congress 2
...er Co. and Wisconsin Gas LLC, collectively known a... for relationship management software to automate...We Energies serves more than 1.1 million electric ...ula and more than one million natural gas customer...on, the utility,s Supply Chain team developed a se...
...al, a supplier of automatic identification and dat...they have introduced version 4.0 of their NiceLabe...clude support for reading and programming radio fr...improved user interface. The system,s modules are ...osoft Access, Windows Event Log and Microsoft Exce...
... an Oconomowoc-based IT services provider, announc...th Cisco Systems . Starting July 1, the campaign ...d communications markets. , ,PDS recently received...m Cisco in the three main areas in which the compa...tions Express, and Wireless. In addition, PDS is c...
...suit on behalf of Wisconsin consumers against Micr..., as a result of last week,s state Supreme Court ...ne Olstad, seeks a settlement fund for all Wiscons...ractices. The suit,s major contention is that Wisc...osoft products, especially the Windows operating s...
Other Biology Technology:Wisconsin Supreme Court rules against Microsoft 2
...ction System is intended for use in the qualitativ...use validated in vitro nucleic acid amplification ...HEMICON XpressPack™ Colorimetric Detection S... detect amplified nucleic acid specific to the tar...
...hambers produce cell yields in the 10 7 - 10 9 ra... bottles or spinner flasks. • High mechanical...00% leak tested prior to shipping • Certified... with low particulate contamination from modern ma...
BD BioCoat Collagen IV 150 mm Culture Dishes
Gridded Cell Culture Petri Dish (20 mm molded in base), tissue-culture treated
Biology Products: